An important feature of our team is our broad operational, business development and management experience from the industry and that we tap into an extensive international network within both the life sciences world. We are determined to add value to our investments and will involve ourselves actively in our portfolio companies and work in close collaboration with their management and boards.
Mette joined Lundbeckfonden Ventures in 2009.
Mette has a broad international experience within biotech / life science covering business development and licensing, management and financing. Mette has been appointed to numerous board positions both in private and public companies.
Mette was previously co-founder and CEO of 7TM Pharma A/S. Prior to founding 7TM Pharma, Mette was part of the management team of NeuroSearch A/S responsible for business development and licensing. She started her career as Patent Agent and has over the years co-founded several biotech companies. Mette Kirstine Agger graduated as Biologist from the University of Copenhagen and has an MBA from Henley Business School.
Johan joined Lundbeckfonden Ventures in 2010.
Before joining Lundbeckfonden Ventures, Johan worked 20 years in the pharma and biotech industry with structural biology, discovery, research management, early development, portfolio management, business development and alliance management.
Johan was previously co-founder and CEO of Sound Biotech ApS and co-founder and Senior Vice President of Research as well as Business Development of Biovitrum AB. Prior to these positions he worked almost a decade in the pharmaceutical company Pharmacia. Johan has co-founded other biotech companies and been serving on numerous boards both in private and public life science companies.
Johan trained as a Physical Chemist at University of Lund, Sweden, Scripps Research Institute, La Jolla, California and Harvard Medical School, Boston, Massachusetts. He is an associate professor in Physical Chemistry at the University of Lund, Sweden.
Casper joined Lundbeckfonden Ventures in 2009.
In his prior work life, Casper gained broad international experience from almost 20 years in the pharma and biotech industry covering areas such as chemistry, project management, outsourcing, international quality audits, business development, alliance management, and general management.
Casper was previously CEO of ilochip A/S, a venture backed company focused on development of diagnostic biochips. Before this he held different positions at H. Lundbeck A/S most recently in corporate business development and strategy. Prior to his work at H. Lundbeck, Casper worked for Novo Nordisk A/S and Niels Clauson-Kaas A/S. While working at H. Lundbeck A/S he was member of the board of directors of Lundbeckfonden and Lundbeckfond Invest A/S as an employee representative. Casper has an MSc in organic chemistry and an MBA in innovation and new business creation, both from the Technical University of Denmark.
Jette assists with the administration and support of the Partners. She has several years of experience in administrative operations and executive assistance.
Prior to joining Lundbeckfonden Ventures in 2014, Jette was employed as Executive Secretary at Bispebjerg Hospital, Department of Anesthesiology.
Before this Jette held different positions as PA at Danske Bank and Danske Securities. Jette is a certified Legal Secretary and Medical Secretary.